Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation

A Randomized Controlled Trial of Radiofrequency Ablation for the Treatment of Paroxysmal Atrial Fibrillation Using the Bard High Density Mesh Ablation System (MAGELLAN)

This is a randomized controlled study of the Bard High Density Mesh Ablation System for treatment of paroxysmal atrial fibrillation. This study will determine if the HD Mesh Ablation System is as safe as and more effective than anti-arrhythmic drugs.

Inclusion Criteria:

• Patients with symptomatic paroxysmal atrial fibrillation who have failed at least one class I or III anti-arrhythmic drug
• Other inclusion criteria

Exclusion Criteria:

• Previous surgical or catheter ablation to treat AF
• Permanent AF
• Uncontrolled or unstable medical conditions
• Other exclusion criteria